2.1. Study subjects
From December 2019 to December 2022, 77 patients from the Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, 36 patients from Huashan Hospital of Fudan University, and 208 patients from Changchun University of Chinese Medicine, a total of 321 cases who met the inclusion criteria were enrolled in this study (Fig. Trial flow chart.